Hoth Therapeutics (NASDAQ:HOTH) Stock Rating Upgraded by Wall Street Zen
Hoth Therapeutics (NASDAQ:HOTH – Get Free Report) was upgraded by Wall Street Zen from a “sell” rating to a “hold” rating in a note issued to investors on Saturday. Separately, D. Boral Capital reissued a “buy” rating and issued a $5.00 target price on shares of Hoth Therapeutics in a research note on Tuesday, April […]
